EFFECT OF XEROGEL ON THE MICROFLORA OF THE LARGE INTESTINE

Authors

  • H. R. Malyarchuk I. Horbachevsky Ternopil National Medical University
  • D. B. Koval I. Horbachevsky Ternopil National Medical University
  • A. L. Shkrobot I. Horbachevsky Ternopil National Medical University

DOI:

https://doi.org/10.11603/1811-2471.2021.v.i4.12807

Keywords:

enterosorbents, xerogel, microflora, enterosorption, large intestine

Abstract

SUMMARY. A lot of attention we paying for methods of treatment wich can cleanse internal environment of our body and remove foreing substances from the body of a sick person.

The aim – to characterise of the effect of enterosorbent on the microflora of the colon.

Material and Methods. The study was conducted on 50 white laboratory rats with an average weight of 200 grams, who were divided into control and experimental groups. The first group consisted of intact rats, the feeding of which was standard. Other rats, which were given Xerogel during normal feeding. In both groups of white rats, the content of the colon was studied, which was obtained using a bacteriological method. The European Convention on the Protection of vertebrate animals used for experimental and other scientific purposes (Strasbourg, 1986).

Results. After 7 and 14 days of taking xerogel, the intestinal stick content in the feces increased by 14 % and 13 %. The content of lactose-negative enterobacteria under the influence of xerogel on the 7th day did not change. On the 14th day the number of lactose-negative enterobacteria decreased under the influence of xerogel by 9 %. After the 7th day of taking xerogel, the content of epidermal staphylococcus decreased by 12 %. During 14 days significantly reduced the content of epidermal staphylococcus by 11.1 %, as well as gold staphylococcus by 20 %. Taking Xerogel on the 7th day of the experiment increased the number of enterococci by 7 %. Enterococcal content in the large intestines of the trial rats increased by 8.36 % after 14 days of taking xerogel. In the feces of the trial rats after 14 days of taking xerogel, the number of bifido and lactobacteria also increased by 36.5 % and 39.3 %, respectively. In relation to anaerobic microorganisms, Xerogel was not significantly affected. Xerogel had a positive effect on microbiocenosis after the 7th day of feeding – the amount of protein decreased by 20 %, and after the 14th day – by 32 %. After taking xerogel, the number of these microorganisms decreased by 17 % (7th day) and 39 % (14th day).

Conclusions. An increase in the content of bifido-, lactobacteria, non-pathogenic bowel sticks and enterococci, as well as a decrease in the number of protea, gold staphylococcus and fungi of the genus Candida in the thick intestine of rats caused the reception of xerogel, which led to the normalization of microbiocenosis, a violation of which was noted in animals of the control group on a fiber-free diet.

References

Mazur, O.O., Plaksyvyi, O.H., Pashkovska, N.V., & Bilooka, I.O. (2016). Stan mikrobioty porozhnyny tovstoho kyshechnyka u khvorykh na tsukrovyi diabet 1-ho typu zalezhno vid viku ta tryvalosti zakhvoriuvannia [The state of the microbiota of the large intestinal cavity in patients with type 1 diabetes mellitus depending on the age and duration of the disease]. Mizhnar. endokrynol. zhurnal – Int. Endocrinol. J., 3(75), 19-24 [in Ukrainian].

Havrylenko, O.M., Layko, A., & Holovnya, O.M. (2014). Mikrobiotsenoz pidnebinnykh myhdalykiv u ditei, khvorykh na tsukrovyi diabet 1-ho typu, z naiavnistiu khronichnoho tonzylitu [Microbiocenosis of the tonsils in children with type 1 diabetes mellitus, with the presence of chronic tonsillitis]. Zhurnal vushnykh, nosovykh i horlovykh khvorob – Journal of Ear, Nose and Throat Diseases, 5, 49-54 [in Ukrainian].

Conlon, M., & Bird, A. (2014). The impact of diet and lifestyle on gut microbiota and human health. Nutrients, 7, 17-44. DOI: 10.3390/nu7010017.

Mejía-León, M.E., & Barca, A.M. (2015). Diet, microbiota and immune system in type 1 diabetes development and evolution. Nutrients, 7(11), 9171-9184. DOI: 10.3390/nu7115461.

Nikolayev, V.H., Klishch, I.M., Zhulkevych, I.V., Oleshchuk, O.M., & Nikolayeva. V.V. Zastosuvannia preparatu Enteroshel dlia profilaktyky oksydatyvnoho stresu pry hostrii krovovtrati [Application of Enterosgel preparation for the prevention of oxidative stress in acute blood loss]. Visnyk naukovykh doslidzhen – Bulletin of Scientific Researches, 1, 72-74 [in Ukrainian].

Shevchuk, O.O. (2020). Efekty enterosorbtsii ta filhrastymu pry subkhronichnii doksorubitsynovii toksychnosti [Effects of enterosorption and filgrastim in subchronic doxorubicin toxicity]. Zdobutky klinichnoi i eksperymentalnoi medytsyny – Achievements of Clinical and Experimental Medicine, 3, 146-156. DOI: https://doi.org/10.11603/1811-2471.2019.v.i3.10510 [in Ukrainian].

Starkel, P., & Leclercq, I.A. (2011). Animal models for the study of hepatic fibrosis. Best Pract. Res. Clin. Gastroenterol., 25(2), 319-333. DOI: 10.1016/j.bpg.2011.02.004.

Cole, N.B., Daniels, M.P., Levine, R.L., & Kim, G. (2010). Oxidative stress causes reversible changes in mitochondrial permeability and structure (Open Access). Exp. Gerontol., 45(7-8), 596-602. DOI: 10.1016/j.exger.2010.01.016.

Hung, G.D., Li, P.C., Lee, H.S., Chang, H.M., Chien, C.T., & Lee, K.L. (2012). Green tea extract supplementation ameliorates CCl4 -induced hepatic oxidative stress, fibrosis, and acute-phase protein expression in rat. J. Formos. Med. Assoc., 111(10), 550-509. DOI: 10.1016/j.jfma.2011.06.026.

Wang, T., Zhao, L.J., Li, P., Jiang, H., Lu, G.C., Zhang, W.D., ..., & Yuan, B.J. (2011). Hepatoprotective effects and mechanisms of dehydrocavidine in rats with carbon tetrachloride-induced hepatic fibrosis. J. Ethnopharmacol., 138(1), 76-84. DOI: 10.1016/j.jep.2011.08.039.

Klaunig, J.E., & Kamendulis, L.M. (2004). The role of oxidative stress in carcinogenesis. Ann. Rev. Pharmacol. Toxicol., 44, 239-267. DOI: 10.1146/annurev.pharmtox.44.101802.121851.

Published

2022-03-25

How to Cite

Malyarchuk, H. R., Koval, D. B., & Shkrobot, A. L. (2022). EFFECT OF XEROGEL ON THE MICROFLORA OF THE LARGE INTESTINE. Achievements of Clinical and Experimental Medicine, (4), 102–106. https://doi.org/10.11603/1811-2471.2021.v.i4.12807

Issue

Section

Оригінальні дослідження